ARTICLES BY THIS AUTHOR
- 2/7/2022
Hy-Vee to debut reimagined store
The store will feature several new departments, as well as amenities the company has become known for. - 2/6/2022
Hy-Vee dietitians to host heart health events throughout February
Hy-Vee dietitians are providing free cholesterol screenings in select locations, and virtual cooking and nutrition classes. - 2/6/2022
Looking forward: Executives size up the state of retail pharmacy in 2022
Drug Store News asked industry experts and those who provide products and services to pharmacies to share their outlook on the pharmacy business. - 2/6/2022
Avalere analysis examines Medicare Part D’s plan tier placement of generics
Avalere’s examination of Medicare Part D plan tier placement of generic prescription drugs found that over time their percentage on generic tiers has declined from 65% in 2016 to 43% in 2022. - 2/6/2022
CVS Health’s, Medable’s clinical trial expands access to underserved communities
The collaboration between the companies combines Medable’s software platform with CVS Health’s community reach and experienced MinuteClinic providers. - 2/3/2022
APhA, NASPA release pharmacy workplace and well-being report findings
The American Pharmacists Association and the National Alliance of State Pharmacy Associations released the first Welcome To Pharmacy Workplace and Well-Being Reporting trends and findings report. - 2/3/2022
Immunocore obtains FDA blessing for Kimmtrak
Kimmtrak is the first TCR therapeutic, the first bispecific T cell engager to treat a solid tumor and the first and only therapy for the treatment of unresectable or metastatic uveal melanoma to be approved by the FDA. - 2/3/2022
Costco reportedly names new president, COO
Costco named executive Ron Vachris as its president and chief operating officer, effective Feb. 2, according to a report. - 2/3/2022
Camber intros generic Focalin
Generic Focalin is a central nervous system stimulant indicated for the treatment of ADHD. - 2/3/2022
CVS Health investing $12.7M in Nashville, Tenn.’s affordable housing community
CVS Health is investing $12.7 million with R4 Capital to build 204 new affordable housing units for individuals and families in Nashville’s Chestnut Hill neighborhood.